Carla Cruz, Elisa Cairrão, Olga Lourenço, Paulo Almeida, Ignacio Verde and João A. Queiroz Polyazamacrocycles as Potential Antitumor Agents for Human Prostate Cancer Cells Chemical Biology & Drug Design 81
Polyazamacrocycles were tested in human prostate cancer LNCaP and prostate epithelial PNTA1. The proliferation rate and viability of LNCaP cells decreased after treatment with the polyazamacrocycles. All the compounds have as main target the Golgi apparatus.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf